| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 0.3 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.005 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.006 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.23 | 0.4 |